Multiple patents contribute to a robust portfolio; however, each patent that issues can potentially become a landmine to another
Kady Bruce, Wolf Greenfield
Advertisement
Articles by Kady Bruce, Wolf Greenfield
Advertisement
Latest Updated Articles
Protecting pharmaceutical exclusivity: Avoiding the hidden dangers of double patentingPublished: January 28th 2021 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
Novo Nordisk’s Bloomington Plant Receives FDA OAI Designation Following Contamination and Compliance Issues
2
United States Delays Tariffs on Singapore’s Pharma Exports Amid Ongoing Trade Negotiations
3
Pharma Pulse: Kaiser Permanente Strike Escalates, Takeda Partners with Nabla Bio, and FDA Flags Novo Nordisk Bloomington Site
4
How Healthcare Organizations Can Balance Federal and State AI Regulations
5
